Frank J.G. Scherpen

845 total citations
33 papers, 592 citations indexed

About

Frank J.G. Scherpen is a scholar working on Molecular Biology, Hematology and Genetics. According to data from OpenAlex, Frank J.G. Scherpen has authored 33 papers receiving a total of 592 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 13 papers in Hematology and 8 papers in Genetics. Recurrent topics in Frank J.G. Scherpen's work include Acute Myeloid Leukemia Research (12 papers), Angiogenesis and VEGF in Cancer (8 papers) and Glioma Diagnosis and Treatment (7 papers). Frank J.G. Scherpen is often cited by papers focused on Acute Myeloid Leukemia Research (12 papers), Angiogenesis and VEGF in Cancer (8 papers) and Glioma Diagnosis and Treatment (7 papers). Frank J.G. Scherpen collaborates with scholars based in Netherlands, United States and Germany. Frank J.G. Scherpen's co-authors include Eveline S.J.M. de Bont, Willem A. Kamps, Arja ter Elst, Eelco W. Hoving, Wilfred F.A. den Dunnen, Maikel P. Peppelenbosch, Sander H. Diks, Kim R. Kampen, Arend H. Sikkema and Victor Guryev and has published in prestigious journals such as Blood, PLoS ONE and Cancer Research.

In The Last Decade

Frank J.G. Scherpen

31 papers receiving 587 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Frank J.G. Scherpen Netherlands	14	363	149	146	103	96	33	592
Valentina Pettirossi Italy	13	444 1.2×	191 1.3×	126 0.9×	194 1.9×	50 0.5×	19	680
Elisabeth Oelmann Germany	16	348 1.0×	83 0.6×	268 1.8×	88 0.9×	102 1.1×	31	773
William Lento United States	12	553 1.5×	281 1.9×	156 1.1×	134 1.3×	126 1.3×	16	880
Joshua Sasine United States	13	279 0.8×	229 1.5×	165 1.1×	90 0.9×	54 0.6×	27	596
Myriam Maoz Israel	17	428 1.2×	301 2.0×	180 1.2×	156 1.5×	298 3.1×	30	902
Katherine Chung United States	9	167 0.5×	107 0.7×	200 1.4×	56 0.5×	61 0.6×	13	661
Deepa Shankar United States	13	649 1.8×	93 0.6×	161 1.1×	31 0.3×	129 1.3×	21	833
Margherita Corbo United Kingdom	7	433 1.2×	103 0.7×	166 1.1×	82 0.8×	40 0.4×	9	599
Victoria Weston United Kingdom	13	671 1.8×	101 0.7×	337 2.3×	175 1.7×	84 0.9×	19	958
Ryu Nakamura Japan	8	510 1.4×	437 2.9×	250 1.7×	107 1.0×	105 1.1×	22	984

Countries citing papers authored by Frank J.G. Scherpen

Since Specialization

Citations

This map shows the geographic impact of Frank J.G. Scherpen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frank J.G. Scherpen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frank J.G. Scherpen more than expected).

Fields of papers citing papers by Frank J.G. Scherpen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frank J.G. Scherpen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frank J.G. Scherpen. The network helps show where Frank J.G. Scherpen may publish in the future.

Co-authorship network of co-authors of Frank J.G. Scherpen

This figure shows the co-authorship network connecting the top 25 collaborators of Frank J.G. Scherpen. A scholar is included among the top collaborators of Frank J.G. Scherpen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frank J.G. Scherpen. Frank J.G. Scherpen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Scherpen, Frank J.G., T. Jeroen N. Hiltermann, Harry J.M. Groen, et al.. (2025). Presence of On-Target Resistant Mutation in Pre-Treatment Samples of ALK Fusion Gene Positive Lung Cancer Patients. Cancers. 17(7). 1090–1090.

Scherpen, Frank J.G., Mirthe H. Schoots, Martha Ritsema, et al.. (2022). The developmental stage of the medulloblastoma cell-of-origin restricts Sonic hedgehog pathway usage and drug sensitivity. Journal of Cell Science. 135(11). 6 indexed citations

Plasschaert, Sabine, et al.. (2021). CREB signaling activity correlates with differentiation and survival in medulloblastoma. Scientific Reports. 11(1). 16077–16077. 5 indexed citations

Rijk, Anke van, Menno Tamminga, Frank J.G. Scherpen, et al.. (2021). Clinical Value of EGFR Copy Number Gain Determined by Amplicon-Based Targeted Next Generation Sequencing in Patients with EGFR-Mutated NSCLC. Targeted Oncology. 16(2). 215–226. 9 indexed citations

Kampen, Kim R., Frank J.G. Scherpen, Hasan Mahmud, et al.. (2018). VEGFC Antibody Therapy Drives Differentiation of AML. Cancer Research. 78(20). 5940–5948. 11 indexed citations

Kampen, Kim R., Frank J.G. Scherpen, Guillermo Garcia‐Manero, et al.. (2015). EphB1 Suppression in Acute Myelogenous Leukemia: Regulating the DNA Damage Control System. Molecular Cancer Research. 13(6). 982–992. 19 indexed citations

Dunnen, Wilfred F.A. den, et al.. (2015). Growth-Factor-Driven Rescue to Receptor Tyrosine Kinase (RTK) Inhibitors through Akt and Erk Phosphorylation in Pediatric Low Grade Astrocytoma and Ependymoma. PLoS ONE. 10(3). e0122555–e0122555. 23 indexed citations

Scherpen, Frank J.G., et al.. (2015). Effect of IKZF1 deletions on signal transduction pathways in Philadelphia chromosome negative pediatric B-cell precursor acute lymphoblastic leukemia (BCP-ALL). Experimental Hematology and Oncology. 4(1). 23–23. 1 indexed citations

Kampen, Kim R., Arja ter Elst, Frank J.G. Scherpen, et al.. (2015). Essential role for cyclic-AMP responsive element binding protein 1 (CREB) in the survival of acute lymphoblastic leukemia. Oncotarget. 6(17). 14970–14981. 25 indexed citations

10.

Sikkema, Arend H., Wilfred F.A. den Dunnen, Esther Hulleman, et al.. (2012). EphB2 activity plays a pivotal role in pediatric medulloblastoma cell adhesion and invasion. Neuro-Oncology. 14(9). 1125–1135. 39 indexed citations

11.

Elst, Arja ter, Bin Ma, Frank J.G. Scherpen, et al.. (2011). Repression of Vascular Endothelial Growth Factor Expression by the Runt-Related Transcription Factor 1 in Acute Myeloid Leukemia. Cancer Research. 71(7). 2761–2771. 27 indexed citations

12.

Elst, Arja ter, Kim R. Kampen, Hendrik J.M. de Jonge, et al.. (2011). Stromal interaction essential for vascular endothelial growth factor A-induced tumour growth via transforming growth factor-β signalling. British Journal of Cancer. 105(12). 1856–1863. 5 indexed citations

13.

Elst, Arja ter, et al.. (2010). VEGF-A promotes lymphoma tumour growth by activation of STAT proteins and inhibition of p27KIP1 via paracrine mechanisms. European Journal of Cancer. 46(5). 974–982. 13 indexed citations

14.

Bont, Eveline S.J.M. de, et al.. (2010). Tumour vasculature and angiogenic profile of paediatric pilocytic astrocytoma; is it much different from glioblastoma?. Neuropathology and Applied Neurobiology. 36(7). 636–647. 44 indexed citations

15.

Elst, Arja ter, Sander H. Diks, Kim R. Kampen, et al.. (2010). Identification of new possible targets for leukemia treatment by kinase activity profiling. Leukemia & lymphoma. 52(1). 122–130. 20 indexed citations

16.

Sikkema, Arend H., Sander H. Diks, Wilfred F.A. den Dunnen, et al.. (2009). Kinome Profiling in Pediatric Brain Tumors as a New Approach for Target Discovery. Cancer Research. 69(14). 5987–5995. 104 indexed citations

17.

Jonge, Hendrik J.M. de, Arja ter Elst, H. Marike Boezen, et al.. (2008). Endogenous Vascular Endothelial Growth Factor-C Expression Is Associated with Decreased Drug Responsiveness in Childhood Acute Myeloid Leukemia. Clinical Cancer Research. 14(3). 924–930. 18 indexed citations

18.

Jonge, Hendrik J.M. de, Arja ter Elst, H. Marike Boezen, et al.. (2006). Endogenous VEGF-C mRNA Expression Increases In Vitro Drug Resistance of Pediatric AML Cells and Is an Independent Prognostic Factor for the Time To Reach Complete Remission in AML.. Blood. 108(11). 838–838. 1 indexed citations

19.

Dolstra, Harry, Hanny Fredrix, A. Balas, et al.. (2002). Bi-directional allelic recognition of the human minor histocompatibility antigen HB-1 by cytotoxic T lymphocytes. European Journal of Immunology. 32(10). 2748–2758. 45 indexed citations

20.

Bont, Eveline S.J.M. de, et al.. (2002). Vascular endothelial growth factor secretion is an independent prognostic factor for relapse-free survival in pediatric acute myeloid leukemia patients.. PubMed. 8(9). 2856–61. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact